Showing results (181-190 of 294) with videos related to

Sort By:
Pageof 30
Hepatology (Baltimore, Md.)|October 24, 2017
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory scienceMohammad Shadab Siddiqui, Stephen A Harrison, Manal F Abdelmalek, et al.
Hepatology (Baltimore, Md.)|June 9, 2021
Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver FibrosisKazuhiro Kozumi, Takahiro Kodama, Hiroki Murai, et al.
Contemporary Clinical Trials|November 9, 2018
European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationaleJake P Mann, Anita Vreugdenhil, Piotr Socha, et al.
Free Radical Biology & Medicine|January 5, 2002
Lipid peroxidation contributes to immune reactions associated with alcoholic liver diseaseElisa Mottaran, Stephen F Stewart, Roberta Rolla, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicityGuruprasad P Aithal, Lesley Ramsay, Ann K Daly, et al.
Hepatology (Baltimore, Md.)|March 12, 2010
A role for the pregnane X receptor in flucloxacillin-induced liver injuryElise Andrews, Martin Armstrong, Jonathan Tugwood, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2013
Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver diseasePaul Angulo, Jacob George, Christopher P Day, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2022
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD)Danielle Brandman, Marie Boyle, Stuart McPherson, et al.
Pageof 30